Greenwood, IN, United States of America

Donald B Boyd

This inventor holds 6 USPTO granted patents and 5 published patent applications. Top assignee: Eli Lilly and Company. Active years: 1995-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald B Boyd. Retrieved from https://idiyas.com/inventor/donald-b-boyd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 11.3

ph-index = 4

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 1995-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Donald B Boyd from Greenwood, IN

Introduction: Donald B Boyd, a prolific inventor hailing from Greenwood, IN, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions and patents.

Latest Patents: Boyd's latest patents revolve around Angiotensin II antagonists. These inventions entail novel heterocyclic derivatives, their pharmaceutical formulations, and their application in antagonizing angiotensin II receptors in mammals.

Career Highlights: With an impressive portfolio of 6 patents, Donald B Boyd has showcased his ingenuity and expertise in the pharmaceutical industry. His work at Eli Lilly and Company has been instrumental in driving innovation and advancing medical research.

Collaborations: Boyd has collaborated with notable peers in his field, including Sherryl L Lifer and Winston S Marshall. Together, they have contributed to the development of cutting-edge pharmaceutical solutions.

Conclusion: Donald B Boyd stands out as a pioneering inventor with a remarkable track record in inventing novel pharmaceutical compounds. His dedication to advancing the healthcare industry through innovation is truly commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…